Infection News

NEW ORLEANS — Children with acute gastroenteritis with dehydration receive unequal treatment in the ED because of race, according to a retrospective analysis of more than 30,000 patients.

SAN ANTONIO — The median time to a first negative stool polymerase chain reaction test after the treatment of Clostridioides difficile infection was 9 days, which indicate when physicians can expect to see a negative test, according to data presented at the American College of Gastroenterology Annual Meeting

SAN ANTONIO — Reprocessing duodenoscopes with double high-level disinfection and liquid chemical sterilization helped produce lower rates of positive cultures from the scopes, but was not able to eliminate them entirely, according to study results presented at the American College of Gastroenterology Annual Meeting.

SAN ANTONIO — The National Liver Congress will convene October 25th, providing a broad scientific program and exhibit of products and services important for all practitioners involved in the care of patients with liver disease.

SAN ANTONIO — Starting this weekend, Healio Gastroenterology and Liver Disease will provide live coverage as the exclusive media partner of the American College of Gastroenterology’s 84th Annual Scientific Meeting.

Over the last 20 years, Helicobacter pylori resistance to clarithromycin — an antibiotic commonly used to treat the infection — has more than doubled in Europe, increasing from 9.9% in 1998 to 21.6% in 2018, according to study findings presented at United European Gastroenterology Week.

CHICAGO — In this exclusive video perspective from the NASPGHAN Annual Meeting, Richard Kellermayer, MD, PhD, medical director of the pediatric inflammatory bowel disease center at the Baylor College of Medicine, Texas Children’s Hospital, discusses his presentation on guidelines and safety in fecal microbiota transplantation for children with recurrent Clostridioides difficile infection.

Recent study data showed disparities in hepatitis B virus infection rates between ethnic groups as well as among between U.S.-born and foreign-born patients.

Patients who developed hepatitis C-related hepatocellular carcinoma after achieving sustained virologic response with interferon-free direct-acting antivirals had a 60% to 70% improvement in 5-year survival compared with untreated patients.

A novel therapy designed to provide prolonged and constant release of antibiotic helped prevent surgical site infections in patients who underwent abdominal surgeries, according to the manufacturer, PolyPid.